Clinical subtypes of stage IV pancreatic ductal adenocarcinoma: a new perspective of clinical practices.

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest malignancies and becomes an increasing burden on our society, with nearly half of patients presenting with metastasis at diagnosis and a mortality rate that continues to rise during…

Preview only. Read the full abstract at the source